Product Information

CELECOXIB 200 MG CAPSULE is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0749 per EA under NDC 68180039901. Its NADAC has been published 353 times since Feb 12, 2020.

FDA first approved this application on Oct 29, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CELECOXIB 200 MG CAPSULE

celecoxib
$0.0749per EA

Strength

200 mg/1

NDC

68180039901

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

CELECOXIB

Approval Type

Generic (ANDA)

FDA Application

ANDA202240

FDA Approved

10/29/2014

TE Code

AB

On Market Since

12/9/2019

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for CELECOXIB 200 MG CAPSULE has been published 353 times since Feb 12, 2020, and over the history we have for it it has declined 56.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0749 per EA
All-time high$0.2000 (Mar 11, 2020)
All-time low$0.0749 (Oct 21, 2026)
52-week high$0.0866
52-week low$0.0749
Median price$0.1115
Average price$0.1214
Largest weekly change+25.0% (Aug 21, 2024)
Weeks tracked353
Tracking sinceFeb 12, 2020

Price History

1W

0.0%

1M

-1.7%

3M

-1.4%

6M

-10.3%

1Y

-13.9%

3Y

-31.8%

5Y

-52.3%

All

-56.0%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CELECOXIB 200 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for CELECOXIB 200 MG CAPSULE, manufactured by Lupin Pharmaceuticals Inc., is $0.0749 per EA (NDC 68180039901), effective Nov 11, 2026.

How has the price of CELECOXIB 200 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for CELECOXIB 200 MG CAPSULE has declined 56.0%. It has been tracked across 353 weekly CMS publications since Feb 12, 2020.

What are the highest and lowest recorded NADAC prices for CELECOXIB 200 MG CAPSULE?

Since Feb 12, 2020, the NADAC for CELECOXIB 200 MG CAPSULE has ranged from a low of $0.0749 (Oct 21, 2026) to a high of $0.2000 (Mar 11, 2020), with a median of $0.1115 per EA.

Are there cheaper alternatives to CELECOXIB 200 MG CAPSULE?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CELECOXIB 200 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures CELECOXIB 200 MG CAPSULE?

CELECOXIB 200 MG CAPSULE (NDC 68180039901) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.